Drug details
Zemaira (alpha-proteinase inhibitor (human))
type of Alpha-1 proteinase inhibitor, Pulmonary, Other
Zemaira [Alpha1-Proteinase Inhibitor (Human)] is a protein (alpha 1-antitrypsin) that occurs naturally in the body. In people who lack the alpha 1-antitrypsin protein, breakdown of lung tissues can lead to emphysema (damage to the air sacs in the lungs). Zemaira is used to treat alpha 1-antitrypsin deficiency in people who have symptoms of emphysema. Alpha 1-antitrypsin deficiency is a genetic (inherited) disorder and Zemaira will not cure this condition. Zemaira may be available in generic form.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- rash,
- lightheadedness,
- confusion,
- fast heartbeats,
- chest pain,
- dizziness,
- seizure,
- severe headache,
- headache,
- wheezing,
- weakness,
- sudden numbness or weakness,
- slurred speech,
- chest tightness,
- muscle or joint pain,
- nausea, and
- Get medical help right away, if you have any of the symptoms listed above.
- flushing (sudden warmth, redness, or tingly feeling),
- problems with vision or balance, and
- fainting (while receiving the injection)
- The most common side effects of Zemaira include:
- cold symptoms (runny or stuffy nose, sneezing, cough, sore throat),
- bruising or bleeding where the medicine was injected
The following drugs are related to Zemaira, either as a replacement or used together:
- Glassia (alpha1 proteinase inhibitor (human) for intravenous administration)